Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Ticlopidine plus aspirin for coronary thrombosis in Kawasaki disease.
M. O'Brien
, I. A. Parness
, E. J. Neufeld
, A. L. Baker
, R. P. Sundel
, J. W. Newburger
Research output
:
Contribution to journal
›
Article
›
peer-review
19
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Ticlopidine plus aspirin for coronary thrombosis in Kawasaki disease.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Aspirin
100%
Kawasaki Disease
100%
Coronary Thrombosis
100%
Ticlopidine
100%
United States
33%
Antithrombotic Therapy
33%
Thrombolytic Therapy
33%
Selective Inhibitor
33%
Thrombus
33%
Platelet Activation
33%
Adenosine Diphosphate
33%
Giant Coronary Artery Aneurysm
33%
Coronary Aneurysm
33%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
100%
Coronary Artery Thrombosis
100%
Mucocutaneous Lymph Node Syndrome
100%
Ticlopidine
100%
Coronary Artery Aneurysm
66%
Antithrombotic Therapy
33%
Adenosine Diphosphate
33%
Fibrinolytic Agent
33%
Thrombus
33%